Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Item 9 Labs Corp. (INLB : OTC)
 
 • Company Description   
Item 9 Labs Corp. is a vertically integrated cannabis operator delivering premium products from its large-scale cultivation and production facilities in the United States. Item 9 Labs Corp. is based in PHOENIX.

Number of Employees: 105

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.93 Daily Weekly Monthly
20 Day Moving Average: 17,244 shares
Shares Outstanding: 94.95 (millions)
Market Capitalization: $88.30 (millions)
Beta: 1.19
52 Week High: $3.74
52 Week Low: $0.83
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -16.96% -6.49%
12 Week -19.83% -11.87%
Year To Date -16.22% 7.88%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2727 NORTH 3RD STREET SUITE 201
-
PHOENIX,AZ 85004
USA
ph: 833-867-6337
fax: -
investors@item9labs.com http://www.item9labscorp.com
 
 • General Corporate Information   
Officers
Andrew Bowden - Chief Executive Officer and Director
Douglas Bowden - Chairman of the Board
Chris Wolven - Chief Operating Officer
Robert Mikkelsen - Chief Financial Officer
Ronald L. Miller - Director

Peer Information
Item 9 Labs Corp. (BJCT)
Item 9 Labs Corp. (CADMQ)
Item 9 Labs Corp. (APNO)
Item 9 Labs Corp. (UPDC)
Item 9 Labs Corp. (IMTIQ)
Item 9 Labs Corp. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 46564C203
SIC: 3843
Fiscal Year
Fiscal Year End: September
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/15/22
Share - Related Items
Shares Outstanding: 94.95
Most Recent Split Date: 10.00 (0.05:1)
Beta: 1.19
Market Capitalization: $88.30 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.03 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.11 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/15/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.07
Price/Cash Flow: -
Price / Sales: 3.45
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: 8.62%
vs. Previous Quarter: 7.31%
ROE
03/31/22 - -17.59
12/31/21 - -11.86
09/30/21 - -11.69
ROA
03/31/22 - -13.56
12/31/21 - -9.82
09/30/21 - -9.78
Current Ratio
03/31/22 - 0.19
12/31/21 - 0.53
09/30/21 - 0.71
Quick Ratio
03/31/22 - -
12/31/21 - 0.20
09/30/21 - 0.28
Operating Margin
03/31/22 - -66.78
12/31/21 - -52.53
09/30/21 - -49.71
Net Margin
03/31/22 - -66.78
12/31/21 - -52.53
09/30/21 - -49.71
Pre-Tax Margin
03/31/22 - -66.75
12/31/21 - -52.53
09/30/21 - -49.72
Book Value
03/31/22 - 0.87
12/31/21 - 0.89
09/30/21 - 0.94
Inventory Turnover
03/31/22 - 3.97
12/31/21 - 5.33
09/30/21 - 8.34
Debt-to-Equity
03/31/22 - 0.02
12/31/21 - 0.19
09/30/21 - 0.17
Debt-to-Capital
03/31/22 - 1.95
12/31/21 - 16.15
09/30/21 - 14.80
 

Powered by Zacks Investment Research ©